Skip to main content
Log in

Postoperative Strahlentherapie beim Prostatakarzinom

Genetischer Risikoscore noch nicht reif für die klinische Routine

  • journal club
  • Published:
InFo Onkologie Aims and scope

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Literatur

  1. Dalela D et al. J Clin Oncol. 2017;35(18):1982–90.

    Article  PubMed  Google Scholar 

  2. Thompson IM et al. J Urol. 2009;181(3):956–62.

    Article  PubMed  PubMed Central  Google Scholar 

  3. Bolla M et al. Lancet. 2012;380(9858):2018–27.

    Article  PubMed  Google Scholar 

  4. Wiegel T et al. J Clin Oncol. 2009;27(18):2924–30.

    Article  PubMed  Google Scholar 

  5. Kalbasi A et al. Cancer. 2014;120(19):3089–96.

    Article  PubMed  PubMed Central  Google Scholar 

  6. Sineshaw HM et al. Eur Urol. 2015;68(5):768–74.

    Article  PubMed  Google Scholar 

  7. Spratt DE et al. J Clin Oncol. 2017;35(18):1991–8.

    Article  PubMed  Google Scholar 

  8. Den RB et al. J Clin Oncol. 2015;33(8):944–51.

    Article  PubMed  PubMed Central  Google Scholar 

  9. Lughezzani G et al. Eur Urol. 2010;57(4):562–8.

    Article  PubMed  Google Scholar 

  10. Stish BJ et al. J Clin Oncol. 2016;34(32):3864–71.

    Article  PubMed  Google Scholar 

Originalie

  • Dalela D et al. Genomic Classifier Augments the Role of Pathological Features in Identifying Optimal Candidates for Adjuvant Radiation Therapy in Patients With Prostate Cancer: Development and Internal Validation of a Multivariable Prognostic Model. J Clin Oncol. 2017; 35(18):1982–90.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Tobias Finazzi.

Additional information

Erstpubliziert in Strahlenther Onkol. 2017;194(1):70-2.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Finazzi, T., Zimmermann, F. Genetischer Risikoscore noch nicht reif für die klinische Routine. Info Onkol. 21, 16–18 (2018). https://doi.org/10.1007/s15004-018-5950-6

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s15004-018-5950-6

Schlüsselwörter

Navigation